FDA Brief

Warning letters Drugs

FDA warning letter to

Jose Miguel Gutierrez Salas

High riskIssued Jul 21, 2022Posted Jul 26, 2022Center for Drug Evaluation and Research | CDER

FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.

What happened

FDA tested a batch of MVP Sanitizing Services SPRAY HAND SANITIZER after it was detained and refused admission at the U.S. border; the product was declared to be made at the firm’s Tepic, Mexico facility. The lab found 0% ethanol and an average of 63% methanol. FDA also cited the firm for not registering the facility, not correctly listing the drugs, and marketing an unapproved and misbranded hand sanitizer.

What FDA found

  1. The hand sanitizer labeled to contain ethanol had 0% ethanol and an average of 63% methanol, so ethanol was substituted with a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The substitution shows the facility’s quality assurance was not functioning under CGMP.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The product is an unapproved new drug because it is not generally recognized as safe and effective and has no approved FDA application.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  4. The label is false or misleading because it says the product contains ethanol, does not disclose methanol, and does not give the proportion of each active ingredient.

    FD&C Act sections 502(j), (a), (e)(1)(A), and (ee), 21 U.S.C. 352(j), (a), (e)(1)(A), (ee); 21 CFR 201.66(c)(2)
  5. The foreign establishment was not registered with FDA and the drugs were not listed with the correct manufacturing establishment.

    FD&C Act sections 510(i), 510(j), 301(p), and 502(o), 21 U.S.C. 360(i), 360(j), 331(p), 352(o)
  6. Methanol is not acceptable as an inactive ingredient because it is not safe and suitable for use.

    21 CFR 330.1(e)

What FDA wants

FDA asks the firm to reply in writing within 15 working days with an investigation of the methanol substitution, raw-material and supplier lists, U.S. shipment and batch records, and the full formulation. FDA also recommends a qualified CGMP consultant if the firm intends to resume making drugs for the U.S. market.

Who should pay attention

  • brands and distributors that buy hand sanitizer from foreign contract manufacturers
  • importers and U.S. agents for foreign drug establishments
  • retailers and consumers relying on ethanol hand sanitizer labels

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk